Lectin-like oxidized LDL receptor-1 (LOX-1) supports adhesion of mononuclear leukocytes and a monocyte-like cell line THP-1 cells under static and flow conditions  by Hayashida, Kazutaka et al.
Lectin-like oxidized LDL receptor-1 (LOX-1) supports adhesion of
mononuclear leukocytes and a monocyte-like cell line THP-1 cells
under static and £ow conditions
Kazutaka Hayashida, Noriaki Kume*, Manabu Minami, Toru Kita
Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
Received 27 September 2001; revised 11 December 2001; accepted 11 December 2001
First published online 28 December 2001
Edited by Veli-Pekka Lehto
Abstract Adhesion of mononuclear leukocytes to vascular
endothelial cells appears one of the initial steps in the process
of atherogenesis and inflammation. We examined if LOX-1, an
endothelial scavenger receptor with C-type lectin-like structure,
can support adhesion of mononuclear leukocytes. Under a static
condition, CHO-K1 cells stably expressing LOX-1 showed more
prominent adhesion of human peripheral blood mononuclear
leukocytes and THP-1 cells than untransfected CHO-K1 cells, in
a temperature-independent fashion. Mononuclear leukocytes also
adhered to plastic plates precoated with recombinant soluble
LOX-1 extracellular domain. A neutralizing anti-LOX-1 mono-
clonal antibody, as well as oxidized low-density lipoprotein,
significantly blocked adhesion of THP-1 cells to CHO-K1
cells overexpressing LOX-1 and bovine aortic endothelial
cells. Under a flow condition, increased numbers of THP-1
cells showed rolling with reduced velocities on LOX-1-
expressing CHO-K1 cells, compared with those on untransfected
CHO-K1 cells. Taken together, LOX-1 can work as a cell sur-
face receptor for mononuclear leukocytes under both static and
flow conditions. ß 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Adhesion of mononuclear leukocytes to vascular endothe-
lial cells has been suggested as one of the initial steps in
atherogenesis as well as in£ammatory responses [1]. Previous
reports have suggested that multiple molecules appear to be
involved at the di¡erent stages of endothelial^leukocyte adhe-
sion, including rolling and ¢rm adhesion [2]. These molecules
include selectins, such as E-selectin, P-selectin, and L-selectin,
and immunoglobulin gene superfamily molecules, including
vascular cell adhesion molecule-1 (VCAM-1) and intercellular
adhesion molecule-1 (ICAM-1) [2]. Studies with mice de¢cient
in genes encoding these adhesion molecules, as well as func-
tional blocking antibodies, have revealed the crucial roles of
these adhesion molecules in leukocyte recruitment in the set-
tings of atherogenesis as well as in£ammation [3^5]; however,
involvement of other adhesion mechanisms also has been sug-
gested [5].
Oxidized low-density lipoprotein receptor-1 (LOX-1) is a 50
kDa type II membrane glycoprotein with C-type lectin-like
structure in the extracellular domain, which acts as an endo-
cytosis receptor for atherogenic oxidized low-density lipopro-
tein (LDL) [6]. LOX-1 is synthesized as a 40 kDa precursor
protein with minimal N-linked high mannose carbohydrate
chains, and subsequently further glycosylated and processed
into a 48^50 kDa mature form [7]. Interestingly, LOX-1 can
be induced by proin£ammatory stimuli, such as tumor ne-
crosis factor-K [8], transforming growth factor-L [9], oxidized
LDL [10] and £uid shear stress [11], suggesting its roles in the
settings of in£ammatory diseases and vascular injury. In vivo,
LOX-1 is highly expressed in endothelial cells covering early
atherosclerotic lesions of humans [12] and hypercholesterole-
mic rabbits [13].
Like other scavenger receptor family molecules [14,15],
LOX-1 has a broad spectrum of physiological ligands, in-
cluding oxidized or aged erythrocytes [16], apoptotic cells
[16], activated platelets [17], bacteria [18], and ¢bronectin
[19]. Therefore, in the present study, we sought to deter-
mine if LOX-1 can support adhesion of mononuclear leuko-
cytes.
2. Materials and methods
2.1. Reagents
Dulbecco’s modi¢ed Eagle’s medium (DMEM), RPMI 1640 me-
dium and Ham’s F12 medium were obtained from Nissui (Tokyo,
Japan). Fetal calf serum (FCS) was purchased from Sanko Junyaku
(Tokyo, Japan). BCECF-AM was from Molecular Probes (Eugene,
OR, USA).
2.2. Cell culture
Wild-type CHO-K1 cells (wild-type CHO) were maintained in F12
medium containing 10% (v/v) heat-inactivated FCS. CHO-K1 cells
stably expressing human LOX-1 (hLOX-1-CHO) were established
by transfection with a pME vector containing the full-length human
LOX-1 and screening the ability to accumulate DiI-labeled oxidized
LDL [6,10]. Cloned cells were maintained in F12/10% fetal bovine
serum (FBS) supplemented with G418 (0.8 mg/ml). CHO-K1 cells
stably expressing bovine LOX-1 (bLOX-1-CHO) were maintained in
F12/10% FCS supplemented with 10 Wg/ml of blasticidin S (Funa-
koshi, Tokyo, Japan) as previously described [6,20]. Cultured bovine
aortic endothelial cells (BAEC) were isolated and cultured as previ-
ously indicated [6,9,11,18,19]. Human peripheral blood mononuclear
leukocytes were isolated from healthy donors by Ficoll density gra-
dient centrifugation [21,22]. THP-1, U-937, and Jurkat cells were ob-
tained from American Type Culture Collection (Rockville, MD,
USA), and cultured in RPMI 1640/10% FCS.
0014-5793 / 02 / $22.00 ß 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 2 9 7 - 5
*Corresponding author. Fax: (81)-75-751 3574.
E-mail address: nkume@kuhp.kyoto-u.ac.jp (N. Kume).
FEBS 25678 21-1-02
FEBS 25678 FEBS Letters 511 (2002) 133^138
2.3. Leukocyte adhesion assay under a static condition
Static leukocyte adhesion assays were performed as previously de-
scribed with minor modi¢cations [21]. In brief, after hLOX-1-CHO,
bLOX-1-CHO, wild-type CHO, or BAEC.6 grown in 96 well plates
were incubated with BCECF-labeled human peripheral blood mono-
nuclear leukocytes, THP-1 cells, U937 cells or Jurkat cells (1U106
cells/ml) suspended in RPMI 1640/10% FBS at 4, 25 or 37‡C for
the indicated time periods, wells were ¢lled with the assay medium,
sealed, inverted, and centrifuged at low speed (270Ug for 25‡C and
37‡C assays, and 50Ug for the 4‡C assay) for 5 min. After non-
adherent leukocytes were removed, cells were dissolved with a lysis
bu¡er consisting of 50 mM Tris pH 8.4 and 0.1% SDS, and the £uo-
rescence was measured in Titertek Fluoroscan II (Flow Laboratories)
[21]. In some experiments, cells were pretreated with a neutralizing
anti-LOX-1 monoclonal antibody (20 Wg/ml) [23], control IgG (20 Wg/
ml), oxidized LDL (20 or 40 Wg/ml), or native LDL (20 or 40 Wg/ml)
for 10 min before addition of BCECF-labeled leukocytes.
2.4. Leukocyte adhesion assay to plates precoated with recombinant
human LOX-1 extracellular domain (rhLOX-1 ECD)
rhLOX-1 ECD was produced in Escherichia coli by transfecting a
cDNA fragment corresponding to the extracellular domain (amino
acids 84^273) of human LOX-1 which had been subcloned into
pQE vector (Qiagen). After precoating with the indicated concentra-
tions of rhLOX-1 ECD for 30 min at 37‡C, cell culture plates were
blocked by incubation with 1% (w/v) heat-denatured (57‡C, 25 min)
bovine serum albumin (BSA) for 1 h at room temperature followed by
washing with phosphate-bu¡ered saline. BCECF-labeled human pe-
ripheral blood mononuclear leukocytes were allowed to adhere to
rhLOX-1 ECD-coated plates by incubation at 37‡C for 30 min. After
non-adherent cells were removed by low speed centrifugation (270Ug,
5 min), adherent cells were dissolved with a lysis bu¡er consisting of
50 mM Tris pH 8.4 and 0.1% SDS, and the £uorescence was mea-
sured in Titertek Fluoroscan II.
2.5. Leukocyte rolling in a £ow chamber
Con£uent wild-type CHO and hLOX-1-CHO were cultured in a
parallel plate £ow chamber (5 mm in width, 0.254 mm in depth).
The £ow chamber was perfused with BCECF-labeled THP-1 cells
(3U105 cells/ml) suspended in RPMI 1640/10% FCS at a £ow rate
corresponding to the indicated shear stress at 22‡C. The leukocyte
movement was recorded by a £uorescence microscope (Zeiss)
equipped with a £uorescence digital videocamera (Hamamatsu). The
rolling velocity of THP-1 cells was determined by capturing two dif-
ferent time frames with a 33 ms delay and measuring lengths of tracks
Fig. 1. Adhesion of human peripheral mononuclear leukocytes and
the related cell lines to CHO-K1 cells stably expressing human
LOX-1 (hLOX-1-CHO). hLOX-1-CHO were incubated with the in-
dicated leukocytes labeled with BCECF-AM to allow them to ad-
here for 30 min at 37‡C. Non-adherent cells were detached by cen-
trifugation at 270Ug for 5 min. Adherent cells were lysed and the
£uorescence was measured (¢lled bars). Untransfected wild-type
CHO-K1 cells (wild-type CHO) served as negative controls (blank
bars). The graph indicates the numbers of adherent leukocytes.
Mean values from 10 wells and S.D. are indicated by columns and
bars respectively. A representative ¢gure from four independent ex-
periments is shown.
Fig. 2. Adhesion of THP-1 cells to hLOX-1-CHO at di¡erent tem-
peratures. After hLOX-1-CHO were incubated with BCECF-labeled
THP-1 cells at the indicated temperature (4, 20, or 37‡C) for 30
min, non-adherent cells were removed by low speed centrifugation
and the cell-associated £uorescence was measured as described in
Section 2. Untransfected wild-type CHO-K1 cells served as negative
controls. THP-1 cell numbers adhered to wild-type CHO were
171 þ 41, 25.5 þ 1.5, and 12.6 þ 2.5 cells/mm2 at 37, 20, and 4‡C, re-
spectively. Relative adherent cell numbers are indicated. Columns
and bars indicate mean values and S.D. calculated from 10 wells for
each experiment. Representative ¢gures from four independent ex-
periments are shown.
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of THP-1 cells on the merged images created with IMAGE 1.62 (Na-
tional Institutes of Health, Bethesda, MD, USA). Slowly moving
THP-1 cells at velocities less than one tenth of the centerline £ow
velocity were de¢ned as rolling cells.
2.6. Statistical analysis
Data were expressed as the mean þ standard deviations (S.D.). Sta-
tistical signi¢cance of the di¡erences between two groups was ana-
lyzed by two-tailed unpaired Student’s t-test. Statistical comparison
between more than two groups was performed by one-factorial AN-
OVA. Post-hoc test was Fischer’s PLSD test. The null hypothesis was
considered to be rejected at P6 0.05.
3. Results
3.1. Adhesion of peripheral blood mononuclear leukocytes and
THP-1 cells to CHO-K1 cells stably expressing LOX-1
under a static condition
To examine if LOX-1 can support adhesion of mononuclear
leukocytes, a static adhesion assay was performed in both
hLOX-1-CHO and untransfected CHO-K1 cells. As shown
in Fig. 1, hLOX-1-CHO showed signi¢cant enhancement of
mononuclear leukocyte and THP-1 cell adhesion, but not
U-937 or Jurkat cell adhesion, when compared to untransfected
wild-type CHO-K1 cells. A 1.5-fold increase was observed in
mononuclear leukocytes, whereas a 3.5-fold increase was seen
in THP-1 cells. Adhesion of THP-1 cells to hLOX-1-CHO was
time-dependently increased for the initial 30 min, and reached
the maximal level after 30 min (data not shown). To explore
temperature dependence in leukocyte^LOX-1 interactions, a
static adhesion assay was carried out in THP-1 cells at 4,
22, and 37‡C. Enhancement of THP-1 cell adhesion to
hLOX-1-CHO, when compared to that to wild-type CHO,
was similarly observed at 4, 22, and 37‡C (Fig. 2), suggesting
that temperature-independent interactions between THP-1
cells and LOX-1 may be involved. These results are quite
di¡erent from the integrin-mediated adhesion of leukocytes
to VCAM-1 or ICAM-1, in which temperature-dependent ac-
tivation of integrins is necessary.
Fig. 3. Adhesion of THP-1 cells and human peripheral blood mono-
nuclear leukocytes to plates precoated with rhLOX-1 ECD. After
precoating with the indicated concentrations of rhLOX-1 ECD, fol-
lowed by blocking with heat-denatured BSA, adhesion of BCECF-
labeled human peripheral blood mononuclear leukocytes was mea-
sured as described in Section 2. Relative adherent cell numbers
(mean values and the S.D.) calculated from 10 wells for each
rhLOX-1 ECD concentration are indicated. Dots indicate means
and bars indicate S.D. A representative ¢gure from four indepen-
dent experiments is indicated.
Fig. 4. A: E¡ects of a neutralizing anti-LOX-1 antibody on THP-1
cell adhesion to LOX-1. After bLOX-1-CHO cells cultured in 96
well plates were incubated with BCECF-labeled THP-1 cells at 37‡C
for 30 min in the presence of a neutralizing anti-bovine LOX-1
monoclonal antibody or subclass-matched control IgG, non-adherent
cells were removed by low speed centrifugation, and the £uorescence
was measured as described in Section 2. THP-1 cell numbers adher-
ent to bLOX-1-CHO and wild-type CHO were 267.1 þ 32.1 and
107.9 þ 10.3 cells/mm2, respectively, in the absence of antibodies.
Relative adherent cell numbers are indicated in the bar graph. Mean
values (columns) and the S.D. (bars) calculated from ¢ve wells for
each adhesion condition are indicated. B: E¡ects of oxidized LDL,
a ligand for LOX-1, on THP-1 cell adhesion to LOX-1. After
hLOX-1-CHO cells cultured in 96 well plates were incubated with
BCECF-labeled THP-1 cells at 4‡C for 30 min in the presence of
oxidized LDL (20 Wg/ml) or native LDL (20 Wg/ml), non-adherent
cells were removed by low speed centrifugation and the £uorescence
was measured as described in Section 2. Wild-type CHO-K1 cells
served as negative controls. THP-1 cell numbers adherent to bLOX-
1-CHO and wild-type CHO were 46.3 þ 3.7 and 26.8 þ 7.9 cells/mm2,
respectively, in the absence of lipoproteins. Relative adherent cell
numbers are indicated. Mean values (columns) and the S.D. (bars)
calculated from ¢ve wells for each adhesion condition are indicated.
Representative ¢gures from four similar experiments are shown.
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3.2. Adhesion of THP-1 cells and human peripheral blood
mononuclear leukocytes to rhLOX-1 ECD
To obtain direct evidence that mononuclear leukocytes and
THP-1 cells adhere to LOX-1, adhesion assays were also per-
formed in plates precoated with rhLOX-1 ECD without cells.
As shown in Fig. 3, THP-1 cells and human peripheral blood
mononuclear leukocytes adhered to plates precoated with
rhLOX-1 ECD in a concentration-dependent manner. Maxi-
Fig. 5. A: E¡ects of a neutralizing anti-LOX-1 monoclonal anti-
body on THP-1 cell adhesion to BAEC. After con£uent monolayers
of BAEC in 96 well plates were incubated with BCECF-labeled
THP-1 cells in the presence or absence of a neutralizing anti-LOX-1
monoclonal antibody or control IgG at 37‡C, non-adherent cells
were removed by low speed centrifugation and the £uorescence was
measured as indicated in Section 2. Adherent THP-1 cell numbers
were 134.2 þ 13.1 cells/mm2 in the absence of antibodies. Relative
adherent cell numbers are indicated. Mean values (columns) and the
S.D. (bars) calculated from ¢ve wells for each adhesion condition
are indicated. B: E¡ects of oxidized LDL on THP-1 cell adhesion
to BAEC. Con£uent monolayers of BAEC in 96 well plates were in-
cubated with BCECF-labeled THP-1 cells in the presence or absence
of 20 Wg/ml of oxidized LDL or native LDL at 4‡C. Non-adherent
cells were removed by low speed centrifugation and the £uorescence
was measured as indicated in Section 2. Adherent THP-1 cell num-
bers were 59.1 þ 11.7 cells/mm2 in the absence of lipoproteins. Rela-
tive adherent cell numbers are indicated. Mean values (columns)
and the S.D. (bars) calculated from ¢ve wells for each adhesion
condition are indicated. Representative ¢gures from four similar ex-
periments are indicated.
µ
Fig. 6. A: Numbers of rolling THP-1 cells on hLOX-1-CHO cells
and untransfected wild-type CHO-K1 cells. BCECF-labeled THP-1
cells were perfused over hLOX-1-CHO cells or wild-type CHO-K1
cells cultured in a £ow chamber at the indicated shear stress. Num-
bers of rolling THP-1 cells were counted as described in Section 2.
Numbers of rolling cells were counted in 10 di¡erent merged images
with time di¡erences of more than 5 s. Mean values (columns) and
the S.D. (bars) calculated from 10 independent merged images are
indicated. B: Rolling velocities of THP-1 cells on hLOX-1-CHO
cells and untransfected wild-type CHO-K1 cells. BCECF-labeled
THP-1 cells were perfused over hLOX-1-CHO cells or wild-type
CHO-K1 cells cultured in a £ow chamber at the indicated shear
stress. Velocities of rolling THP-1 cells were measured as described
in Section 2. Columns indicate means and bars indicate S.D. of roll-
ing velocities calculated from 50 independent THP-1 cells. Represen-
tative ¢gures from four independent experiments are shown.
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mal adhesion was observed at 10 Wg/ml of rhLOX-1 ECD and
the adhesion was saturated at 20 Wg/ml.
3.3. E¡ects of a neutralizing anti-LOX-1 monoclonal antibody
and oxidized LDL on THP-1 cell adhesion to LOX-1
A neutralizing anti-LOX-1 monoclonal antibody, which in-
hibits binding of oxidized LDL to LOX-1, partly (by 72% of
the LOX-1-dependent adhesion) but signi¢cantly inhibited ad-
hesion of THP-1 cells to CHO-K1 cells stably expressing bo-
vine LOX-1 (bLOX-1-CHO). A subclass-matched control IgG
did not signi¢cantly a¡ect THP-1 cell adhesion to bLOX-1-
CHO. In wild-type CHO-K1 cells, in contrast, the neutralizing
anti-LOX-1 antibody did not inhibit adhesion of THP-1 cells
(Fig. 4A). THP-1 cell adhesion to bLOX-1-CHO was also
signi¢cantly (by almost 100% of the LOX-1-dependent adhe-
sion) inhibited by oxidized LDL, but not native LDL (Fig.
4B), suggesting that binding sites on LOX-1 for THP-1 cells
and oxidized LDL overlap.
3.4. E¡ects of a neutralizing anti-LOX-1 monoclonal antibody
and oxidized LDL on THP-1 cell adhesion to BAEC
To explore if LOX-1 on the cell surface of BAEC can sup-
port adhesion of leukocytes, an adhesion assay was similarly
carried out in BAEC by use of the neutralizing anti-LOX-1
monoclonal antibody. As shown in Fig. 5A, THP-1 cell adhe-
sion to BAEC was signi¢cantly (by 40%) inhibited by the anti-
LOX-1 monoclonal antibody but not control IgG. In addi-
tion, oxidized LDL, but not native LDL, suppressed THP-1
adhesion to BAEC by 78% (Fig. 5B). These results thus in-
dicate that LOX-1 plays a signi¢cant role in THP-1 cell adhe-
sion to BAEC.
3.5. LOX-1 supports rolling of THP-1 cells under a £ow
condition
To explore if LOX-1 can support rolling under a £ow con-
dition, we examined rolling velocity of THP-1 cells on both
bLOX-1-CHO and wild-type CHO by use of a £ow chamber
(Fig. 6A). As shown in Fig. 6B, the velocity was reduced by
43% in THP-1 cells rolling on hLOX-1-CHO when compared
with those rolling on wild-type CHO. Velocities of non-inter-
acting THP-1 cells were not signi¢cantly di¡erent between
bLOX-1-CHO and wild-type CHO (data not shown).
4. Discussion
LOX-1 has a wide variety of pathophysiological ligands,
such as aged/apoptotic cells [16], activated platelets [17], bac-
teria [18], and ¢bronectin [19], in addition to oxidized LDL
[6,20]. The present study demonstrates, for the ¢rst time, that
LOX-1 can support adhesion of mononuclear leukocytes and
related cell lines under both static and £ow conditions.
Endothelial^leukocyte adhesion can be supported by multi-
ple molecular interactions, including selectins^carbohydrates
and immunoglobulin gene superfamily molecules^integrins
[2]. In addition to these molecular interactions, LOX-1 may
also be involved in adhesion of mononuclear leukocytes. As
shown in Fig. 2B, LOX-1 can support cell adhesion at 4‡C,
suggesting that integrins may not be the counter receptor of
LOX-1. In addition, LOX-1 can support rolling of THP-1
cells under low shear £ow conditions (less than 1 dyne/cm2).
Previous studies with selectins have shown that selectins sup-
port rolling most e¡ectively at the threshold levels of shear
rates, and lower shear rates do not support rolling interactions
su⁄ciently [24]. In contrast to selectins, LOX-1 appears to
support rolling of THP-1 cells more e¡ectively under slower
£ow conditions. LOX-1 may be able to support rolling and
adhesion of leukocytes at the later stages of leukocyte^endo-
thelial interactions, after the selectin-mediated rolling. Inter-
estingly, LOX-1 expression is drastically induced by proin-
£ammatory stimuli [8,9], as well as oxidized LDL [10],
which are related to vascular dysfunction including athero-
genesis [1]. In addition, endothelial expression of LOX-1 is
upregulated in cells covering early phases of atherosclerotic
lesions [12,13]. Recruitment of mononuclear leukocytes is
the prominent feature of both atherogenesis and in£amma-
tion. LOX-1 may, thus, play a role in leukocyte recruitment
in these pathological settings, in cooperation with selectins
and immunoglobulin gene superfamily molecules [2].
Because oxidized LDL can inhibit LOX-1^THP-1 interac-
tions, binding sites for oxidized LDL and THP-1 cells on the
LOX-1 molecule appear overlapped. Counter receptors for
LOX-1 on THP-1 cells and mononuclear leukocytes remain
to be identi¢ed; however, they should be abundantly ex-
pressed on the cell surface of THP-1 cells, as well as mono-
nuclear leukocytes, but not U-937 or Jurkat cells. Previous
studies have indicated that LOX-1 may transmit biological
signals after ligation with its ligands, such as oxidized LDL
[25] and activated platelets [17]. It remains to be determined
whether binding of leukocytes to LOX-1 can transmit biolog-
ical signals to vascular endothelial cells.
In summary, the present report provides evidence, for the
¢rst time, that LOX-1 can support adhesion of mononuclear
leukocytes and THP-1 cells, the related cell line, under both
static and £ow conditions. Further studies related to function-
al blockade and overexpression of this unique scavenger re-
ceptor may provide novel insights into the roles of LOX-1 in
the pathogenesis of vascular dysfunction.
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